PubMedCrossRef 4. Arthur DW, Vicini FA: Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 2005, 23:1726–1735.PubMedCrossRef 5. Pinnarò P, Soriani A, Landoni V, Giordano C, Papale M, Marsella A, Marucci L, Arcangeli G, Strigari L: Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years. J Exp Clin Cancer Res 2010, 29:9.PubMedCrossRef 6.
Bentzen SM, Yarnold JR: Reports of unexpected late side effects of accelerated partial breast irradiation–radiobiological considerations. Int J Radiat Oncol Biol Phys 2010, 77:969–973.PubMedCrossRef 7. Hepel JT, Tokita M, MacAusland SG, et al.: Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2009, 75:1290–1296.PubMedCrossRef 8. Pinnarò ��-Nicotinamide clinical trial P, Arcangeli S, Giordano C, Arcangeli G, Impiombato FA, Pinzi V, Iaccarino G, Soriani A, Landoni V, Strigari L: Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer. Radiat Oncol 2011, 6:155.PubMedCrossRef 9. Denham JW, Hauer-Jensen M: The radiotherapeutic injury–a complex ‘wound’. Radiother Oncol selleck chemical 2002, 63:129–145.PubMedCrossRef
10. Riley P: Free radicals in biology: oxidative stress and the effects of ionizing irradiation. Int J Radiat Biol 1994, 65:27–33.PubMedCrossRef 11. Edvardsen H, Kristensen VN, Grenaker Alnaes GI, Bøhn M, Erikstein B, Helland A, Børresen-Dale AL, Fosså SD: Germline glutathione S-transferase variants in breast cancer: relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1163–1171.PubMedCrossRef 12. Bentzen SM: NCT-501 preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 2006, 6:702–713.PubMedCrossRef 13. Yin Z, Ivanov VN, Habelhah H, Tew K, Ronai Z: Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress
kinases. Cancer Res 2000, 60:4053–4057.PubMed 14. Manevich Y, Clomifene Feinstein SI, Fisher AB: Activation of the antioxidant enzyme 1-CYS peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proc Natl Acad Sci USA 2004, 101:3780–3785.PubMedCrossRef 15. Wu Y, Fan Y, Xue B, Luo L, Shen J, Zhang S, Jiang Y, Yin Z: Human glutathione S-transferase P1–1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 2006, 25:5787–5800.PubMedCrossRef 16. Ambrosone CB, Tian C, Ahn J, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Chang-Claude J: Genetic predictors of acute toxicitiesrelated to radiation therapy following lump ectomy for breast cancer: a case-series study. Breast Cancer Res 2006, 8:R40.PubMedCrossRef 17. Hoeijmakers JH: Genome maintenance mechanisms for preventing cancer.